CURRENT TEAM Mark Howarth, Professor

Mark did graduate work in molecular immunology at Oxford University Institute of Molecular Medicine and Southampton

University Cancer Sciences. In his postdoctoral work at MIT, working with Alice Ting and 2023 Nobel Laureate Moungi Bawendi, he

developed tools in chemical biology, advanced microscopy and nanotechnology to understand receptor trafficking. He was

Professor of Protein Nanotechnology at Oxford University, moving to Cambridge University to take up the Sheild Chair in the

Department of Pharmacology in 2022. In 2017 he was awarded the Royal Society of Chemistry Norman Heatley Prize for chemical

biology and helped to found SpyBiotech, taking the group’s vaccine approach into clinical trials. Several of the lab’s alumni have

founded their own companies, with Mark acting as Translational Champion for the Department and currently spinning out a new

company. His work has been funded by ERC, BBSRC, EPSRC, MRC, Wellcome Trust and through collaborations with companies

including Sekisui Diagnostics, AB Vista and Sony.

Danye Chen, PhD student

Danye did her undergraduate training at Imperial College London in Chemistry and is generating tools to accelerate the discovery

of drug synergy.

Yujia Cui, PhD student

Yujia is originally from China and did her Bachelor’s in Pharmacology at McGill University where she researched Protein Kinase C

signalling. Her project is on developing delivery approaches to improve vaccine protection.

Josh Poon, Part II student

Josh is studying medicine at Sidney Sussex College Cambridge and designing enhanced superglue technology.

Gabrielle Admans, PhD student

Gabrielle did her Masters at the University of Glasgow, including a year’s placement with GlaxoSmithKline. She is currently

establishing platforms to enhance vaccine generation. She is also Co-President of the Climate Synthetic Biology Society.

Emily Nassen, PhD student

Emily studied at Ghent University and researched nanocarriers in cancer cell death. She is now engineering assemblies to target

protective immune responses.

Dawid Maciorowski, MD/PhD student

Dawid is a member of the NIH OxCam scholars programme, carrying out his clinical training at the University of Wisconsin-

Madison, as well as research jointly at NIH and with our lab on Herpes Simplex Virus vaccine development.

Lasya Vankayala, DPhil student

Lasya studied at the University of British Columbia, where she founded COVID19 Demystified, and is developing covalent

conjugation to enhance cell therapy.

Bharath Sivasritharan, Part II student

Bharath is a medical student at Emmanuel College Cambridge, researching molecular assembly technology.

Ana Rossi, PhD

Ana is developing ultrastable antibody mimetics for targeting in the GI tract and is one of the founders of Gastrobody

Therapeutics.

Jing Wang, PhD

Jing completed her graduate work at Peking University on next generation immune analysis and is now working to enhance

modular cell therapy of cancer.

For information on joining this lab.

FIND FORMER MEMBERS

Anne-Marie Andersson, CTO at immunotherapy spin-out Hervoluton Therapeutics

Miriam O’Duill, Assistant Prof. at University of Nottingham

Niels Wicke, CSO and Co-founder at Zya

Theodora Bruun, MD/PhD at Stanford Medical School

Denis Krndija, Group leader at Centre de Biologie Intégrative (CBI), Toulouse

Robert Wieduwild, researcher at Rudolf-Schönheimer-Institut für Biochemie, University of Leipzig

Apurba Koner, Professor at Indian Institute of Science Education and Research

Rolle Rahikainen, PI at University of Tampere

Irsyad Khairil Anuar, founder at Valink Therapeutics

Arne Scheu, founder at Valink Therapeutics

Sarah Rouse UKRI Future Leaders Fellow at Imperial College London

Jacob Fierer, Director of Business Development, Technology transfer

at Weizmann Institute

Gianluca Veggiani, Assistant Professor at Louisiana State University

Michael Fairhead at the Centre for Medicines Discovery, University of Oxford

Paul Moody at Oxford Nanopore

Catharina Melzer, Senior Consultant at Bayer

Rory Hills, Department of Pathology, Stanford University

Raphael Gayet, founder of Florey Biosciences

Dominic Wood, University of Manchester

Anthony Keeble, Cambridge University

Kanlaya Prapainop Katewongsa, Associate Prof. at Mahidol University, Thailand

Alberto Carella, patenting at Kilburn & Strode Attorneys

Claudia Driscoll, Laboratory of Evolutionary Design, Stanford University

Jayati Jain, Executive Director at Fluid AI, co-founder with Trutech Webs and the Fluid Motion

Anselm Schneider at Nuvisan Pharma

Felix Metzner, Gene Center at Ludwig Maximilian University of Munich

Christopher Schoene at Hoffmann Eitle Patent

Emily Chittock at Carpmaels & Ransford Intellectual Property

Bijan Zakeri, at Thermo Fisher Scientific

Linda Tchatchouang at GenScript

Vikash Yadav, Lecturer at University of Derby

Sam Stokes at UK Intellectual Property Office

Sheryl Lim A*STAR Institute of Molecular and Cell Biology, Singapore

David Schramm, Foundation Doctor at Northampton General Hospital

Jisoo Jean, Strategic Projects Manager for Shionogi Europe

James Ross, EPSRC Synthetic Biology Research Fellow at University of Leeds

Karl Brune, Crick Institute and founder at Genie Biotech

Can Buldun at BB Biotech investment

Anthony Walsh at Formation Bio

Vincent Fideli at London Centre for Nanotechnology

Jamie Lam, Joint PhD Student at University of Hong Kong (HKU) and University of Toronto

Max Jamilly, Co-founder at Hoxton Farms biotech

Susan Vester at King’s College London

Hung-Jen Wu at Emory University School of Medicine

Georgi Nikov at Valink Therapeutics

Aastha Chokshi, Resident Physician at Brown University/Rhode Island Hospital

Sandra Oloketuyi, Los Alamos National Laboratory

Jenny Hayes, University of York

Michael Jacobsen at Novo Nordisk

Anusuya Banerjee, Senior Scientist at GSK